In this episode of the LSWA podcast, host Tracey Wilkinson interviews Fleta Solomon and Michael Winlo, two experts in the field of psychedelic-assisted therapy and medical cannabis. They discuss the potential of these treatments to revolutionise mental health care and provide a more holistic approach to patient care. The conversation begins with a focus on the use of cannabis to achieve high THC effects for certain patients. Fleta and Mike emphasise the importance of therapy in every...

In this episode of the LSWA podcast, host Tracey Wilkinson sits down with Natalie Barber, the director of Clinical Operations at Chrysalis Advisory, and Professor Peter Richmond from the University of Western Australia.  Natalie and Peter discuss their respective roles in the clinical trial space. Peter, a paediatrician, focuses on improving children's health by conducting research on vaccines and monoclonal antibodies. He shares his involvement in every stage of the clinical trial process,...

In this episode of the Investor Meets Innovator Podcast, host Peter Birch sits down with Paul Anderson, the Managing Director of Orthocell. With over 25 years of experience in the medical space and a background in device development and regenerative medicine, Paul shares his insights on the life sciences industry and the journey of bringing innovative medical technologies to market. Paul discusses the challenges and opportunities in the healthcare industry, particularly in Western Australia...

In this episode of LSWA Investor Meets Innovator, Host Tracey Wilkinson talks with Simon Handford and Angela Fonceca about the challenges and complexities of tech transfer offices and taking research to commercialisation. They discuss the challenges of taking an innovation from academia and industry, the slow pace of negotiations, issues with funding commitments from industry partners, and the role of technology transfer offices in aiding researchers. They talk about the importance of...

In this episode of the Investor Meets Innovator Podcast, host Peter Birch is joined by Ian Brown, Executive Chairman, and Intan Oldakowska, Chief Scientific Officer, of Rex Ortho. They discuss the journey of Rex Ortho, a platform technology company focused on orthopaedic fixations, particularly in proximal femoral fractures. Intan shares the background of Rex Ortho, which started in 2012 when she and her co-founder, Matt Oldakowski, were approached by a surgeon with a need for a solution to...

In this episode of the Investor Meets Innovator Podcast, host Peter Birch speaks with Arjun Balaji, an analyst with a clinical background at Tenmile, a venture capital firm in Perth, Western Australia. Arjun shares his background in medicine and his journey into the world of biotech startups before transitioning to investing. In this episode Arjun discusses the importance of bridging the gap between clinicians and the technologies they use day-to-day. He highlights how investing in life...

In this episode of the Investor Meets Innovator Podcast, host Peter Birch sits down with Dr Melissa McBurnie, Partner and Head of Impact at Brandon Capital.    You will hear about how Brandon Capital approaches investing with impact in the life sciences and get some insights into the processes that they use when making an investment in this space.  You will also learn about the role balancing financial returns plays in creating positive impact. Links & Resources: - AusBiotech:...

In this episode of the Life Sciences WA Podcast, Dr Tara Speranza discusses her work as a healthcare and biotech analyst at Bell Potter Securities. Dr Speranza is part of a group of three analysts who cover the healthcare and biotech sector in Australia, focusing on companies listed on the ASX. She has a background in molecular biology and endocrinology and has worked on various projects in the pharmaceutical industry. Dr Speranza explains that as an analyst, she focuses on analysing the...

Investment in life sciences in Western Australia is an area of great interest, as shown by the recent Life Sciences WA podcast episode featuring guests Greg Riebe and Steve Elias. Riebe is a company director and angel investor with decades of experience in commercialising emerging technologies and is currently a Commercialisation Facilitator for the AusIndustry Accelerating Commercialisation service, while Elias has over 20 years of experience in the field, including working with the federal...

This episode features conversations with Paul Watt, Co-Founder and Executive Chair of Avicena Systems and Liddy McCall, Director of Yuuwa Ventures Investment in life sciences in Western Australia has grown significantly in recent years. This growth has been driven by several factors, including the state's strong research and development infrastructure, its highly educated workforce, and its supportive government policies. In an interview on the Life Sciences WA Podcast, local investor Liddy...

In this episode of the Life Sciences WA Podcast, Dr Bi Mian discusses his work with the Australian Medical Angels, a medical syndicate that focuses on investing in HealthTech start-ups in Australia. Dr Mian, who is a medical doctor and runs a multi-specialist medical centre in regional New South Wales, founded the group with his co-founder Dr Amandeep Hansra. The group, which has 600 members, is unique in that it consists of verified clinicians across the medical and dental fields. Dr Mian...

In this podcast episode of the Life Sciences WA Podcast, the guest was Bronwyn LeGrice, CEO of ANDHealth. The focus of the discussion was on investing and commercialising digital health. LeGrice introduced herself and discussed her background, which included seven years in venture capital and over 20 years in the commercialisation of medical technologies, including setting up and Health. She explained that ANDHealth is Australia's only dedicated digital health commercialisation company. When...

Dr Alma Fulurija Dr Alma Fulurija is the Head of the Strep A Vaccines team at Telephone Kids Institute. In this interview, she discussed the process of vaccine development, which is a long, expensive, and high-risk process, but has the potential for high rewards if successful. The Covid-19 pandemic has shown that vaccine development can be done faster with more money and collaboration. Dr Fulurija discussed the different phases of vaccine development, including the discovery phase, where...

Glenn Butcher is the CEO of FundWA, a venture capital firm focused on investing in technology-enabled innovation businesses in Western Australia. In this interview, he discussed the potential for growth and success in this area, highlighting the state's strong track record in life sciences research and the potential for commercialising this research into products and services. Butcher discussed the different types of organisations and products that might be of interest to investors in the...